baber/WOPTO huggingface dataset:
Patent NZ-601932-A (NZ)
Title: Fatty acid acetylated salicylates and their uses
Inventor: MILNE JILL C
IPC: A61K31/165
Filed: 2009-07-08
Abstract: Disclosed is a molecular conjugate comprising a salicylate and a fatty acid wherein the fatty acid is selected from the group consisting of omega-3 fatty acids and fatty acids that are metabolized in vivo to omega-3 fatty acids, wherein the conjugate: is stable to oral dosing; is stable in plasma; and is capable of enzymatic hydrolysis to produce free salicylate and free fatty acid; wherein the conjugate after hydrolysis blunts pro-inflammatory activity and activates anti-inflammatory activity. The fatty acid is selected from the group consisting of all cis-7, 10, 13-hexadecatrienoic acid, a-linolenic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid, docosahexaenoic acid (DHA), tetracosapentaenoic acid, and tetracosahexaenoic acid. The salicylate is selected from salicylic acid, substituted salicylate, aminosalicylic acid, diflunisal and triflusal.
Patent NZ-604012-A (NZ)
Title: Shut down of rotating irrigator if extension arm deviates from planned position
Inventor: PFRENGER JOCHEN
IPC: B05B15/68
Filed: 2012-12-05
Abstract: 604012 Whilst the main boom assembly 14 of a center pivot 12 irrigator 14 is rotating the irrigator controller 42 determines the actual position of the end tower 26 of the main boom and determines the actual angular orientation ? of the extension arm 16 relative to the end tower. If the actual angular orientation ? deviates from a desired angular orientation that is stored in the controller memory by more than a threshold amount, the operation of the irrigator is shut down. The desired angular orientation is associated in the memory with the position of the end tower with respect to the boundaries of the field to be irrigated.
Patent NZ-606144-A (NZ)
Title: Reprocessable liquid cartridge for liquid ejecting device
Inventor: ITO NORITSUGU
IPC: B41J2/175
Filed: 2011-07-28
Abstract: Disclosed is a reprocessable or refurbishable printer liquid ink cartridge that uses an electrical connection with the printer to determine if the internal ink path from the interior of the cartridge to an external port has been formed for fluid transfer. The printer cartridge (40) includes a replaceable sensor (140). A storing portion (42) stores liquid and a liquid path (43) is for a fluid communication between the storing portion (42) and a device which the liquid cartridge is to be installed. A movable member (60) moves inside the liquid path between a position to allow the flow of the liquid and another position to stop the flow of the liquid. A sensor (140) outputs signals corresponding to the positions of the movable member (60). A memory (141) stores at least values corresponding to the signals and the product life of the sensor (140). A controller (100) examines the values in the memory whether or not the sensor (140) is to be replaced and the liquid cartridge (40) is to be reprocessed and be refurbished.
Patent NZ-611981-A (NZ)
Title: Treatment of immune-related diseases and disorders using amnion derived adherent cells
Inventor: ABBOT STEWART
IPC: A61K35/12
Filed: 2011-12-15
Abstract: Disclosed is a use of amnion-derived adherent cells (AMDACs) in the preparation of a medicament for treating an individual having or at risk of developing a disease or disorder associated with or caused by an inappropriate or unwanted immune response, wherein the AMDACs (i) are OCT-4– as determinable by RT-PCR, (ii) are adherent to tissue culture plastic, (iii) are not amniotic epithelial cells; and (iv) do not comprise human totipotent cells and wherein the disease or disorder is not cardiomyopathy.
Patent NZ-617461-A (NZ)
Title: A prosthetic device and method of manufacturing the same
Inventor: MORTARINO ENRICO
IPC: D04B21/12
Filed: 2012-04-17
Abstract: A biocompatible surgical silk mesh prosthetic device employs a knit pattern that substantially prevents unraveling and preserves the stability of the mesh device, especially when the mesh device is cut. An example prosthetic device employs a knitted mesh including at least two yarns laid in a knit direction and engaging each other to define a plurality of nodes. The at least two yarns include a first yarn and a second yarn extending between and forming loops about two nodes. The second yarn has a higher tension at the two nodes than the first yarn. The second yarn substantially prevents the first yarn from moving at the two nodes and substantially prevents the knitted mesh from unraveling at the nodes.
Patent NZ-619142-A (NZ)
Title: Product gas concentrator and method associated therewith
Inventor: SPRINKLE THOMAS B
IPC: B01D53/04
Filed: 2008-04-21
Abstract: Disclosed is an apparatus for providing a concentrated product gas using two sieve tanks that provide elevated concentrations of oxygen in a breathing gas for medical patients and flight personnel. The apparatus for providing a concentrated product gas comprises an input device to select a first desired output setting for the concentrated product gas and a product gas source to provide the concentrated product gas for dispensing. A pressure sensor monitors a pressure of the concentrated product gas. A conserver valve comprises an output connection to a user, a vent connection to a vent port, and a gas connection to the concentrated product gas, where the output connection is switched from the vent connection to the gas connection and vice versa. A controller in operative communication with the input device and pressure sensor selectively switches the conserver valve to selectively dispense a bolus of concentrated product gas based at least in part on the selected output setting and monitored pressure. The controller is configured to compare a pressure summation to a pressure summation threshold of the bolus. A flow sensor monitors a flow indicative of a breathing cycle for the user; where the controller is in operative communication with the flow sensor. The flow sensor determines a breathing characteristic of the user based at least in part on the monitored flow, and selectively switches the conserver valve bases at least in part on the determined breathing characteristic. The controller determines a start time for dispensing the bolus of concentrated product gas to the user via the output connection based at least in part on a relation between the determined breathing characteristic and a trigger threshold indicative of inhalation.
Patent NZ-624876-A (NZ)
Title: Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
Inventor: BERGMANN ANDREAS
IPC: C07K16/26
Filed: 2012-11-16
Abstract: Discloses use of an anti-Adrenomedullin (ADM) antibody or an anti-ADM antibody fragment binding to adrenomedullin or anti-ADM non-Ig scaffold binding to adrenomedullin in the manufacture of a medicament for use in therapy of an acute disease or acute condition of a patient for stabilizing the systemic circulation of said patient, and wherein said antibody or antibody fragment or non-Ig scaffold binds to a region of at least 4 amino acids within sequence of aa1-42 of mature human ADM (SEQ ID NO: 24), wherein the sequence is as defined in the complete specification.
Patent NZ-628292-A (NZ)
Title: Pluripotent germ layer origin antigen presenting cancer vaccine
Inventor: CORNFORTH ANDREW
IPC: A61K35/15
Filed: 2013-01-31
Abstract: Disclosed is a composition for treating a cancer other than melanoma comprising a population of mammalian dendritic cells comprising cancer-specific peptides from cancer cells taken from a subject that has a cancer other than melanoma; wherein (a) the cancer-specific peptides are acquired in vitro by dendritic cells from said cancer cells; (b) the cancer cells are not treated in vitro with interferon-gamma (IFN-gamma) or an IFN-gamma mimetic; (c) said cancer cells that are not treated in vitro with IFN-gamma or IFN-gamma mimetic, are enriched for autophagic and non-apoptotic cancer cells such that greater than 60% of said cancer cells are autophagic and non-apoptotic, and; (d) the dendritic cells and cancer cells are from the same subject.
Patent NZ-628549-A (NZ)
Title: Novel class of glyphosate resistance genes
Inventor: LIRA JUSTIN M
IPC: C12N15/82
Filed: 2013-02-01
Abstract: An isolated nucleic acid molecule encoding a Class IV EPSPS polypeptide and methods of generating a plant resistant to glyphosate.
Patent NZ-711989-A (NZ)
Title: Method of synthesising a bicyclooctanone
Inventor: VAN WITENBURG JIMMY
IPC: C07C49/633
Filed: 2013-03-11
Abstract: Described is a method of synthesizing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0] octan-3-one by reacting 3-(5-ethoxyhept-1-yl) cyclopentene with dichloroketene. The resulting reaction products are reacted with acetic acid and zinc to produce 4-(5-ethoxyhept-1 -yl)bicyclo[3.2.0]heptan-6-one and 4-(5-ethoxyhept-1-yl)bicyclo [3.2.0]heptan-7-one, which are reacted with trimethylsulfonium iodide to produce 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2’-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2’-oxirane]. Lithium iodide is reacted with 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2’-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2’-oxirane] to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one. A method of synthesizing 6-(5-methoxyhept-1-yl)bicyclo[3.3.0]octan-3-one is also described.
Patent NZ-723571-A (NZ)
Title: New solvated crystal form of rifaximin, production, compositions and uses thereof
Inventor: VISCOMI GIUSEPPE CLAUDIO
IPC: C07D498/22
Filed: 2015-05-07
Abstract: The invention describes a new crystalline form of rifaximin, characterized in that it is a diethylene glycol monoethyl ether solvated form of rifaximin called rifaximin τ (Tau). The invention also describes a process for the preparation of rifaximin τ, a pharmaceutical composition comprising said rifaximin form, and its use for treating inflammations and infections.
Patent NZ-725860-A (NZ)
Title: Indole derivatives for use in medicine
Inventor: COWLEY PHILLIP
IPC: C07D409/12
Filed: 2015-03-19
Abstract: Provided is a tryptophan-2,3-dioxygenase (TDO) and/or indoleamine-2,3-dioxygenase (IDO) inhibitor compound for use in medicine, which compound comprises the following formula: wherein X1, X2, X3, X4, and X5 may be the same or different and each is independently selected from C, N and O; each atom having a dotted line may independently have a double bond or a single bond, provided that valencies at each atom are maintained; each R1, R2, R3, R4, R5, and R7 may be present or absent and may be the same or different and is selected from H and a substituted or unsubstituted organic group, provided that the number of such R groups present is such that the valencies of X1, X2, X3, X4, and X5 are maintained; one or two R6 groups may be present and are selected from H and a substituted or unsubstituted organic group, provided that the number of R6 groups present is such that the valency of the carbon atom to which they are attached is maintained, and provided that at least one R6 is an organic group comprising an atom double-bonded to an oxygen atom (preferably a carbonyl group or a sulphonyl group) at an α-, β-, or γ-position to the carbon atom to which the R6 is attached and in which the atom double-bonded to an oxygen atom is also bonded to a hetero-atom.
Patent NZ-727818-A (NZ)
Title: Pyrazole compounds and their use as t-type calcium channel blockers
Inventor: SIEGRIST ROMAIN
IPC: A61P9/00
Filed: 2015-06-02
Abstract: The invention relates to compounds of formula (I) wherein X, Y, R1, R2, (R4)n, and (R5)m are as defined in the description, and to pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium T-channel blockers.
Patent NZ-728359-A (NZ)
Title: Crystalline (2s)-3-[(3s,4s)-3-[(1r)-1-hydroxyethyl]-4-(4-methoxy-3-{ [1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy} phenyl) -3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol
Inventor: HUANG PING
IPC: C07D205/04
Filed: 2015-08-28
Abstract: The invention provides crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{ [1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy} phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, and pharmaceutical compositions thereof. The invention further provides methods of using this compound to treat overactive bladder.
Patent NZ-733800-A (NZ)
Title: Compounds containing carbon-carbon linker as gpr120 agonists
Inventor: SHARMA RAJIV
IPC: C07D333/12
Filed: 2016-02-02
Abstract: The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a polymorph, N -oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor.
Patent NZ-737021-A (NZ)
Title: Dispensing assemblies and related methods
Inventor: VOELKER SCOTT C
IPC: B05B11/00
Filed: 2013-10-14
Abstract: A dispensing assembly which overcomes a need for improved packaging, shipping and storing. The dispensing assembly includes a container having a handle located toward an upper portion of the container, and a sprayer having an arm extending away from the sprayer. The arm of the sprayer defines a channel configured to receive at least part of the handle of the container within the channel to thereby couple the sprayer to the container. Such a dispensing assembly can be made by forming the container with a handle located toward an upper portion of the container, and forming the sprayer with the arm such that the arm can be used to couple the sprayer to the handle of the container, where the arm extends away from the sprayer and defines the channel for receiving at least part of the handle of the container into the channel.
Patent NZ-737485-A (NZ)
Title: Safety valve for an automatic dairy animal milker unit backflusher and teat dip applicator
Inventor: HEDLUND NATHAN
IPC: A01J7/02
Filed: 2010-09-03
Abstract: A safety valve for use in a dairy back-flushing and dipping system is disclosed. The safety valve is situated on or near a milker unit to seal and protect downstream dairy milk lines from teat dip and cleaning fluids that are fed through the safety valve to upstream milker unit components. All of the fluids, including dip, cleansers, water, and air pass through and are controlled by the safety valve. The safety valve comprises a first valve (324); a second valve (325); a third valve (302); and a valve member (268) that moves the safety valve between a closed position, in which the first valve and the second valve are closed, and the third valve is open to a vent (B5); and an open position, in which the first valve and the second valve are open to a fluid flow channel between the first valve and the second valve, and the third valve is closed to the vent. The valve prevents migration of disinfectant and teat dip through valves and seals into the milk lines by supplying a pair of spaced apart valves and a vent or “bleed” to atmosphere.
Patent NZ-738496-A (NZ)
Title: Cys80 conjugated immunoglobulins
Inventor: GRASSO LUIGI
IPC: C07K16/28
Filed: 2016-06-17
Abstract: Provided herein are methods for generating conjugated immunoglobulins, the method comprising: decapping a cysteine at amino acid position 80 (”Cys80”) in a light chain variable region of an immunoglobulin, wherein the immunoglobulin comprises a heavy chain variable region and the light chain variable region; and conjugating a thiol-reactive compound to the Cys80, wherein the thiol-reactive compound comprises a thiol-reactive group. Antigen-binding molecules and methods for generating the same, immunoglobulins as well as nucleic acid molecules encoding the immunoglobulins and host cells comprising the nucleic acid molecules, conjugated immunoglobulins, and light chain variable regions for use in a conjugated immunoglobulin are also provided.
Patent NZ-745661-A (NZ)
Title: Fluorescence activated cell sorting (facs) enrichment to generate plants
Inventor: SPANGENBERG GERMAN
IPC: C12Q1/24
Filed: 2013-09-09
Abstract: This disclosure concerns methods for selecting plant cells comprising an exogenous polynucleotide and a fluorescent marker (for example, in a transgenic event), and further concerns methods for producing regenerable plant cell cultures from such plant cells. In some embodiments, individual alginate-encapsulated plant cells comprising the polynucleotide and fluorescent marker are separated from other plant cells by fluorescence-activated cell sorting (FACS).
Patent NZ-750285-A (NZ)
Title: Nasal assembly
Inventor: GUNEY MEMDUH
IPC: A61M16/06
Filed: 2004-02-20
Abstract: A nasal interface for delivering pressurized breathable gas to a user. The nasal interface includes a support frame (516) having a central portion and first and second integrally formed connector portions (526) located on respective lateral sides of the support frame, a silicone pillows cushion removably coupled with the support frame and including a base portion and a pair of nozzles (550), an inlet tube to deliver pressurized breathable gas and headgear including a first and second straps (592) adapted to pass around or over the user’s head, and first and second depending side straps each suspended from a respective junction between the first and second straps. The first and second depending side straps are configured to extend forwardly of the ear along the user’s face. The nasal interface includes first and second stiffeners (580) engaged with the respective integrally formed connector portions and depending side straps.
Patent NZ-752994-A (NZ)
Title: Portable device and method for product lighting control, product display lighting method and system, method for controlling product lighting, and -method for setting product display location lighting
Inventor: PAS IRENEUS JOHANNES
IPC: G09F13/00
Filed: 2014-05-01
Abstract: A product display area may be fitted with a particular lighting without regard to the effect the lighting has on the overall product presentation. Disclosed herein is a product display lighting system. The product display lighting system comprises a product display apparatus having product display locations for products. Each product display location contains at least one light source. The product display lighting system further comprises product display apparatus control device for controlling product lighting settings for each product display location. The product display apparatus control device is configured to receive information from a consumer device, the information indicating a search for a product. The product display apparatus control device is further configured to select predetermined product lighting settings for a product display location associated with the product. The information from the consumer device further indicates a consumer location, and the product display apparatus control device further is configured to select a product display location associated with the product nearest to the consumer location.
Patent NZ-757969-A (NZ)
Title: Quantifying robustness by analyzing a property graph data model
Inventor: GIANETTO DAVID AARON
IPC: G06Q10/06
Filed: 2018-03-14
Abstract: A method for quantifying robustness of a system architecture, the method comprising: extracting information from one or more source databases comprising information pertaining to a system architecture, the extracted information pertaining to a plurality of parts of a parts hierarchy of the system architecture and a plurality of interfaces between parts of an interface hierarchy of the system architecture; generating a first data structure representing a weighted property graph data model, the first data structure including a plurality of vertices representing the plurality of parts, a plurality of weighted compositional edges connecting different pairs of vertices of the plurality of vertices and representing hierarchical directed-compositions or directed-decompositions of the plurality of parts, and a plurality of weighted interface edges connecting different pairs of vertices of the plurality of vertices and representing connections between the plurality of parts according to one or more interfaces of the plurality of interfaces; generating a plurality of second data structures up to a number of the plurality of weighted interface edges by, for each of the plurality of second data structures, removing a weighted interface edge in decreasing quantile order, according to a given quantile sample step size of edge betweenness centrality resulting in a plurality of versions of the first data structure having increasing numbers of removed weighted interface edges, including one for each quantile sample; generating a first edge betweenness hierarchical cluster of the first data structure; generating a plurality of second edge betweenness hierarchical clusters of the second data structures, each of the plurality of second edge betweenness hierarchical clusters being of a corresponding one of the plurality of second data structures; and calculating a correlation between the first edge betweenness hierarchical cluster and the second edge betweenness hierarchical clusters, including calculating a plurality of correlations, each of the plurality of correlations being between the first edge betweenness hierarchical cluster and a corresponding one of the plurality of second edge betweenness hierarchical clusters; calculating robustness to narrow attack where the probability of edge removal is less than 0.5 by a median correlation between the first edge betweenness hierarchical cluster and the second edge betweenness hierarchical cluster for the plurality of second data structures with an edge betweenness quantile less than a threshold value; and calculating robustness to broad attack where the probability of edge removal is equal to or greater than 0.5 by the median correlation between the first edge betweenness hierarchical cluster and the second edge betweenness hierarchical cluster for the plurality of second data structures where each removed edge has a betweenness centrality quantile greater than or equal to the threshold value.
Patent NZ-776983-A (NZ)
Title: Cleaner equipped with auxiliary cleaning part
Inventor: YANG HYE JUNG
IPC: A47L13/02
Filed: 2019-05-23
Abstract: The present invention relates to a cleaner equipped with an auxiliary cleaning part and, more specifically, to a cleaner equipped with an auxiliary cleaning part, the cleaner comprising: a rod-shaped grip part extending in a vertical direction; a rigid cleaning part which has a tubular-shaped housing coupled to a lower end portion of the grip part, and has a plurality of frames that are arranged so as to be spaced a predetermined distance from each other from a lower portion of the housing; and an auxiliary cleaning part which is coupled to a lower end portion of the cleaning part and comes into contact with a cleaning target as the cleaning part is deformed.
Patent NZ-780848-A (NZ)
Title: A device for storing elements
Inventor: JEAN-CLAUDE MONGRENIER
IPC: G06K7/00
Filed: 2017-10-02
Abstract: The invention relates to a device (22) for storing elements (12), each element (12) comprising a first wireless communication unit, the device (22) comprising at least one drawer block (30) comprising: - a drawer comprising a bottom defining at least one slot for receiving an element (12), - for each slot, a second wireless communication unit able to transmit radiofrequency waves and adapted for communicating with the whole of the first communication units, the bottom of the drawer being formed with a material able to be crossed by radiofrequency waves transmitted by each second communication unit, each second communication unit being positioned below the bottom of the drawer facing the corresponding slot so as to allow communication between said second communication unit and the first communication unit of an element (12) received in said slot.